Literature DB >> 11220746

Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus.

I J Sutton1, C J Fursdon Davis, M M Esiri, S Hughes, E R Amyes, A Vincent.   

Abstract

Serum antibodies to the Yo antigen are usually associated with paraneoplastic cerebellar degeneration arising in female patients with gynecological or breast malignancy and are rarely associated with other tumors. We report a male patient who presented with paraneoplastic cerebellar degeneration and anti-Yo antibodies following removal of an esophageal adenocarcinoma. This is only the third report of anti-Yo antibodies occurring in a male patient. The Yo antigen was expressed by the esophageal tumor but not in a frontal lobe cerebral metastasis identified at postmortem. Interestingly, CD8+ T-cell infiltration was also found in the tumor, but not in the metastasis, consistent with down-regulation of Yo expression by the tumor cells leading to evasion from immune-mediated tumor surveillance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11220746     DOI: 10.1002/1531-8249(20010201)49:2<253::aid-ana47>3.0.co;2-3

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

1.  A follow up study of patients with paraneoplastic neurological disease in the United Kingdom.

Authors:  P M Candler; P E Hart; M Barnett; R Weil; J H Rees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

2.  Anti-Ri antibodies and limbic encephalitis in a patient with carcinoid tumour of the lung.

Authors:  Andreas Harloff; Sibylla Hummel; Manuela Kleinschmidt; Sebastian Rauer
Journal:  J Neurol       Date:  2005-04-13       Impact factor: 4.849

3.  [Relapsing reversible posterior leukoencephalopathy after chemotherapy with cisplatin and 5-fluorouracil].

Authors:  F Paul; O Aktas; F-J Dieste; P Kreitsch; H-P Vogel; F Zipp
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

4.  Paraneoplastic cerebellar degeneration and anti-Yo antibodies in a man with prostatic adenocarcinoma.

Authors:  J Matschke; A Kromminga; A Erbersdobler; K Lamszus; S Anders; E Köfüncü
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-22       Impact factor: 10.154

5.  Opsoclonus myoclonus syndrome due to squamous cell carcinoma of the oesophagus.

Authors:  Alexander M Rossor; Fiona Perry; Abrie Botha; Fiona Norwood
Journal:  BMJ Case Rep       Date:  2014-03-03

6.  Paraneoplastic Cerebellar Degeneration in Nasopharyngeal Carcinoma: a Unique Association.

Authors:  S Bhardwaj; S Khasani; D Benasher; E G Stein; T Meghal; N Jacoby; Y J Huang
Journal:  Cerebellum       Date:  2019-12       Impact factor: 3.648

Review 7.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

8.  Paraneoplastic Cerebellar Degeneration Associated With Ovarian Adenocarcinoma: A Case Report and Review of Literature.

Authors:  Pushpendra Nath Renjen; Dinesh Mohan Chaudhari; U S Shilpi; Dhruv Zutshi; Kamal Ahmad
Journal:  Ann Indian Acad Neurol       Date:  2018 Oct-Dec       Impact factor: 1.383

9.  Anti-yo associated paraneoplastic cerebellar degeneration in a man with large cell cancer of the lung.

Authors:  Linda Hasadsri; James Lee; Bonnie H Wang; Lalitha Yekkirala; Mingtao Wang
Journal:  Case Rep Neurol Med       Date:  2013-09-19

Review 10.  Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review.

Authors:  Anand Venkatraman; Puneet Opal
Journal:  Ann Clin Transl Neurol       Date:  2016-06-30       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.